DEC
04
NECS welcomes new social worker
Cathy Lounsbury will assist Kennebunk patients
New England Cancer Specialists is pleased to welcome Cathy Lounsbury, Ed.D., LCPC, to our Kennebunk office.
OCT
12
Transparency in Drug Costs
Pharmacy Benefit Managers and fee manipulation
Pharmacy benefit managers (PBMs) have found a new way to manipulate pharmacies to their advantage - and the disadvantage of cancer patients.
SEP
05
NECS Announces New Topsham Office
Brunswick Office Will Move in Spring 2018
New England Cancer Specialists (NECS), Maine's leading oncology practice, has announced plans to relocate its Midcoast office (currently in Brunswick) to a new, state-of-the art facility in Topsham next spring.
AUG
10
CPAN Chapter Launch 8/17
An opportunity for patients and the community
New England Cancer Specialists is teaming up with Community Oncology Alliance (COA) Patient Advocacy Network (CPAN) to launch a local chapter, and you're invited!
JUL
27
The Future of Cancer Research | News
In the conclusion to our month-long celebration of research at NECS, Dr. Christian Thomas looks ahead to what's next for doctors and patients in community oncology.
JUL
20
Roy Jenkin's Story
Participating in a Clinical Trial
In 2013, Roy joined one of the first immunotherapy trials NECS offered for advanced lung cancer.
JUL
06
A Celebration of Research
The NECS Commitment to Innovation
This month, we're celebrating our commitment to innovation and clinical trials.
JUL
05
NECS welcomes Dr. Brian Haney
Accomplished physician joins Brunswick team
New England Cancer Specialists is thrilled to welcome Brian Haney, DO, to our Brunswick office. Dr. Haney joins our other two Brunswick physicians, Dr. David Benton and Dr. Eleni Nackos.
MAY
12
NECS welcomes Joan Lunden
Journalist & TV Host speaks at local conference
New England Cancer Specialists was host to a special Hospice of Southern Maine breakfast on May 11th, featuring Joan Lunden.
MAY
01
NECS CEO talks PBMs
Steven D'Amato on national panel at Community Oncology Conference
Our CEO, Steven D'Amato, spoke on a panel last week in Maryland about the role of pharmacy benefit managers (PBMs) in escalating drug prices, and the associated impact on patients and community oncology practices.
